Evidence map›Paper›PMID 30957099›Full record

ArticleEC microbiology2019

Onchocerciasis in Mozambique: An Unknown Condition for Health Professionals.

Emilia Virginia Noormahomed, Carmen Mascaró-Lazcano

Open access · greenAbstract read
In one paragraph

Article in EC microbiology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.6field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 2 countries.

Emilia Virginia NoormahomedDepartment of Parasitology Laboratory, Microbiology , Faculty of Medicine, Eduardo Mondlane University, Maputo, Mozambique.
Carmen Mascaró-LazcanoDepartment of Parasitology, Universidad de Granada, Granada, Spain.
Universidad de Granada · ESUniversity of California, San Diego · US

Funding

The University Eduardo Mondlane/UCSD Health-Professional Education Partnership InitiativeR25TW011216 · FIC · EDUARDO MONDLANE UNIVERSITY · PI NOORMAHOMED, EMILIA VIRGINIA · 2018 to 2022
$3.2M
Enhanced Advanced Biomedical Research Training for MozambiqueD43TW010135 · FIC · EDUARDO MONDLANE UNIVERSITY · PI NOORMAHOMED, EMILIA VIRGINIA · 2015 to 2019
$3.2M
FIC NIH HHS D43 TW010135
6 · The paper itself

Abstract

introductionOnchocerciasis, remains an unfamiliar condition for health professionals in Mozambique leading to its misdiagnosis as leprosy or scabies as noted in previous studies. Meta-analyses conducted in some African countries, have concluded that onchocerciasis is associated with epilepsy and nodding syndrome. Epilepsy affects at least 3% of the Mozambican population.

aimWe aim to discuss the possible misdiagnosis of scabies and/or leprosy in cases of onchocerciasis as well as insights into a putative role for onchocerciasis in the etiology of epilepsy. Based on these issues, we also highlight some priorities for future onchocerciasis research.

methodsWe carried out a literature review of the epidemiology of onchocerciasis in Mozambique and other parts of the world where the disease exists, its clinical features, and information on the prevalence of epilepsy, scabies and leprosy in Mozambique. RESULTS AND

conclusionsA number of studies (1997 - 2007) revealed that onchocerciasis is present in at least five provinces of Mozambique, comprising 47% of the country's population, and at least three provinces of Mozambique where onchocerciasis has been reported are those where the incidence of leprosy is also high. This increases the possibility that onchocerciasis cases could be misdiagnosed as leprosy or scabies, as seen in previous studies by Noormahomed., et al. In addition, onchocerciasis may contribute to the development of epilepsy at an early age, as has been found in some other African countries such as Tanzania and the Democratic Republic of Congo.Mozambique is not included in many epidemiological maps of onchocerciasis prevalence, while Tanzania and Malawi are listed as endemic countries and have well established community drug treatment with ivermectin, probably because the disease was considered hypoendemic in previous studies. Research should be carried out in focal areas to determine the burden and clinical features of onchocercal disease in Mozambique, as well as, the socio and economic impact of disease in the affected patients and communities. With these data in hand, it will also be possible to assess the possible association of onchocerciasis with epilepsy in Mozambique. It will be equally important to train health professionals in the diagnosis and management of this neglected and poverty-related disease.

Indexed as

EpilepsyLeprosyMisdiagnosisMozambiqueOnchocerciasisScabiesSimulium spp

Identifiers

PMID30957099
PMCPMC6448571
OpenAlexW2982056365

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.